Article Text

Download PDFPDF
Psychotropic medication: curing illness or creating problems?

Statistics from Altmetric.com

Footnotes

  • Competing interests KJ and MJSL have undertaken a Wellcome Trust-funded case-control study of drug antecedents of sudden death. MJSL has received a fee for speaking from Bayer GmbH and has received consulting fees from Galpharm and from Procter and Gamble. Consulting fees from Merck and Co Inc have been paid to the University of Birmingham. MJSL is also an honorary consultant to the WHO Collaborative Centre for International Drug monitoring in Uppsala. MJSL’s wife holds shares in GlaxoSmithKline.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles